Frontlight ResearchEarly access
CompletedPhase 1/2
Safety and Efficacy of Early Administration of Dexamethasone in High-risk Sepsis
Key facts
- Who runs it
- CHA University
- Where
- South Korea2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 1/2
- People taking part
- 102 people enrolled
- Started
- 1 Mar 2022
- Ended
- 28 Feb 2026
- Type of study
- Interventional, 3 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Dexamethasone
- Record updated
- 15 June 2026
Who can take part
- Age
- 19 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Sepsis defined by Sepsis-3 definition
- Initial systolic blood pressure < 90mmHg or blood lactate level >2mmol/L
Who cannot take part
- recent systemic administration of chemotherapy (4 weeks)
- advanced directive for "Do not resuscitation"
- recent systemic administration of glucocorticoid (4 weeks)
- recent systemic administration of immunosuppressant (4 weeks)
- expected life less than 90 days
- Transferred from other hospital
- Sepsis diagnosed 24 hours after ED admission
- Use of etomidate in ED
- pregnant or on lactation
- no informed consent
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of this study is to investigate the safety and efficacy of early administration of two different doses of dexamethasone in high risk septic patients.
The 3 groups in the trial
- PlaceboNo study treatment, for comparison
normal saline
- low dose dexamethasoneTreatment being tested
0.1 mg/kg dexamethasone iv once per day, for 1 or 2 days
Treatment: Dexamethasone
- high dose dexamethasoneTreatment being tested
0.2 mg/kg dexamethasone iv once per day, for 1 or 2 days
Treatment: Dexamethasone
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Randomized, Double-blind, Multi-center Clinical Trial to Evaluate the Safety and Efficacy of Early Administration of Dexamethasone in High-risk Sepsis
- Publications
- The DEXA-SEPSIS study protocol: a phase II randomized double-blinded controlled trial of the effect of early dexamethasone in high-risk sepsis patients.Clinical and experimental emergency medicine, 2022
- Record updated
- 15 June 2026